About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Phoenix | 174 Studies

Clinical Trials HypertensionPhoenix

Hypertension Clinical Trials in Phoenix

Find 174 clinical trials for hypertension near Phoenix, Arizona. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 174 trials

CompletedPORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.NCT02382016·Phoenix, Arizona and 51 others

Hypertension Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedImatinib (QTI571) in Pulmonary Arterial HypertensionA multinational, multicenter, double blind, placebo-controlled study evaluating the efficacy and safety of imatinib as an add-on therapy in the treatment of patients with severe…NCT00902174·Birmingham, Alabama and 94 others

TerminatedA Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial HypertensionStudy will assess PF-00489791 efficacy and safety in Pulmonary Arterial Hypertension (PAH)NCT00853112·Phoenix, Arizona and 24 others

CompletedEfficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With AlbuminuriaThis is a randomized, double-blind (DB), placebo controlled, crossover study with a two-period, two-sequence (2x2) design evaluating the efficacy and safety of 25 mg QD…NCT06150924·Glendale, Arizona and 43 others

TerminatedOpen-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEFThis was an open-label study to evaluate the safety of continued therapy with oral treprostinil in subjects who completed Study TDE-HF-301.NCT03043651·Birmingham, Alabama and 81 others

CompletedA Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH PatientsStudy ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific…NCT03626688·Birmingham, Alabama and 208 others

WithdrawnDose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial HypertensionThe purpose of this study is to determine the safety and maximum tolerated dose of inhaled NX1011 for the treatment of pulmonary arterial hypertension (PAH).NCT00323024·Phoenix, Arizona and 5 others

Active not recruitingA Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive PatientsThe purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at different dose levels in patients…NCT06857955·Andalusia, Alabama and 72 others

CompletedSafety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFEThis was a multicenter, randomized (1:1 inhaled treprostinil: placebo), double-blinded, placebo-controlled trial to evaluate the safety and efficacy of inhaled treprostinil in…NCT02630316·Birmingham, Alabama and 96 others

CompletedEfficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and HypertensionThis study is carried out to assess whether dapagliflozin lowers blood glucose, body weight and blood pressure, when added to patients existing medications and how it compares…NCT01031680·Gulf Shores, Alabama and 139 others

CompletedA Registry for Patients Taking UptraviThis is a US multi-center, prospective, real world, observational drug registry enrolling patients actively treated with Uptravi.NCT03278002·Mobile, Alabama and 84 others

CompletedA Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial HypertensionThe main objective of the study is to assess the effect of treprostinil palmitil inhalation powder (TPIP) compared with placebo on pulmonary vascular resistance.NCT05147805·Phoenix, Arizona and 91 others

CompletedIrbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionThe purpose of this clinical research is to learn if severe hypertension can be better controlled by initially treating with a combination of drugs (Irbesartan/HCTZ), in patients…NCT00095394·Birmingham, Alabama and 268 others

CompletedRemodulin® to Oral Treprostinil TransitionThis multi-center, open-label study will assess the tolerability and safety of transitioning subjects with stable Pulmonary Arterial Hypertension (PAH) from continuous intravenous…NCT01588405·Phoenix, Arizona and 5 others

CompletedStop Atherosclerosis in Native Diabetics StudyCompared to standard treatment goals achieving lower targets for LDL cholesterol (bad cholesterol) and blood pressure in people with diabetes will slow the progression of…NCT00147251·Chinle, Arizona and 3 others

TerminatedInhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)IMPAHCT-FUL: Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (LTE) Trial was a follow up study to establish the long-term safety of…NCT05557942·Phoenix, Arizona and 71 others

CompletedRetrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United StatesThe Opsumit Users registry (OPUS; NCT02126943) was developed to characterize the safety profile of Opsumit and to describe clinical characteristics and outcomes of patients newly…NCT03197688·Phoenix, Arizona and 105 others

TerminatedA Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial HypertensionThis is a multi-center, open-label study of sitaxsentan sodium 100 mg taken orally once daily by subjects with PAH until sitaxsentan, in a particular country or region, is…NCT00811018·Birmingham, Alabama and 90 others

RecruitingMulti-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionMOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease…NCT06911632·Birmingham, Alabama and 36 others

UnknownA Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary FibrosisA randomized, double-blind, placebo-controlled dose escalation study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) in subjects with pulmonary fibrosis on…NCT05747508·Phoenix, Arizona and 22 others

Page 1 of 9Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia